Cargando…
Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis
BACKGROUND: Nasopharyngeal carcinoma (NPC) has a distinctive geographic distribution and is characterised by its strong tendency of metastasis. We aimed to examine the microRNA (miRNA) expression profiles in plasma samples of NPC patients to explore their clinical significance in disease development...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899774/ https://www.ncbi.nlm.nih.gov/pubmed/24327016 http://dx.doi.org/10.1038/bjc.2013.751 |
_version_ | 1782300623432056832 |
---|---|
author | Lu, J Xu, X Liu, X Peng, Y Zhang, B Wang, L Luo, H Peng, X Li, G Tian, W He, M Li, X |
author_facet | Lu, J Xu, X Liu, X Peng, Y Zhang, B Wang, L Luo, H Peng, X Li, G Tian, W He, M Li, X |
author_sort | Lu, J |
collection | PubMed |
description | BACKGROUND: Nasopharyngeal carcinoma (NPC) has a distinctive geographic distribution and is characterised by its strong tendency of metastasis. We aimed to examine the microRNA (miRNA) expression profiles in plasma samples of NPC patients to explore their clinical significance in disease development and progression. METHODS: This study was divided into four steps: (1) confirmation of differentially expressed miRNAs using microarray analysis and quantitative PCR validation; (2) comparison of plasma miR-9 levels during NPC progression; (3) evaluation of the predictive performance of plasma miR-9 as a biomarker for NPC metastasis; and (4) comparison of plasma miR-9 levels between pre- and post-treatment samples. RESULTS: Plasma microarray profiling identified 33 differentially expressed miRNAs between NPC patients and healthy volunteers. The significantly declined level of miR-9 in NPC patients was confirmed through two-stage validation. The low level of plasma miR-9 was significantly correlated with worse lymphatic invasion and advanced TNM stage. The plasma miR-9 could distinguish locoregional from metastatic NPC cases with a high sensitivity and specificity. Furthermore, the plasma miR-9 level was significantly elevated in post-treatment plasma compared with those pre-treatment samples. CONCLUSION: Our study reports that plasma miR-9 may serve as a useful biomarker to predict NPC metastasis and to monitor tumour dynamics. |
format | Online Article Text |
id | pubmed-3899774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-38997742015-01-21 Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis Lu, J Xu, X Liu, X Peng, Y Zhang, B Wang, L Luo, H Peng, X Li, G Tian, W He, M Li, X Br J Cancer Molecular Diagnostics BACKGROUND: Nasopharyngeal carcinoma (NPC) has a distinctive geographic distribution and is characterised by its strong tendency of metastasis. We aimed to examine the microRNA (miRNA) expression profiles in plasma samples of NPC patients to explore their clinical significance in disease development and progression. METHODS: This study was divided into four steps: (1) confirmation of differentially expressed miRNAs using microarray analysis and quantitative PCR validation; (2) comparison of plasma miR-9 levels during NPC progression; (3) evaluation of the predictive performance of plasma miR-9 as a biomarker for NPC metastasis; and (4) comparison of plasma miR-9 levels between pre- and post-treatment samples. RESULTS: Plasma microarray profiling identified 33 differentially expressed miRNAs between NPC patients and healthy volunteers. The significantly declined level of miR-9 in NPC patients was confirmed through two-stage validation. The low level of plasma miR-9 was significantly correlated with worse lymphatic invasion and advanced TNM stage. The plasma miR-9 could distinguish locoregional from metastatic NPC cases with a high sensitivity and specificity. Furthermore, the plasma miR-9 level was significantly elevated in post-treatment plasma compared with those pre-treatment samples. CONCLUSION: Our study reports that plasma miR-9 may serve as a useful biomarker to predict NPC metastasis and to monitor tumour dynamics. Nature Publishing Group 2014-01-21 2013-12-10 /pmc/articles/PMC3899774/ /pubmed/24327016 http://dx.doi.org/10.1038/bjc.2013.751 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Molecular Diagnostics Lu, J Xu, X Liu, X Peng, Y Zhang, B Wang, L Luo, H Peng, X Li, G Tian, W He, M Li, X Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis |
title | Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis |
title_full | Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis |
title_fullStr | Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis |
title_full_unstemmed | Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis |
title_short | Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis |
title_sort | predictive value of mir-9 as a potential biomarker for nasopharyngeal carcinoma metastasis |
topic | Molecular Diagnostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899774/ https://www.ncbi.nlm.nih.gov/pubmed/24327016 http://dx.doi.org/10.1038/bjc.2013.751 |
work_keys_str_mv | AT luj predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT xux predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT liux predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT pengy predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT zhangb predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT wangl predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT luoh predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT pengx predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT lig predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT tianw predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT hem predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis AT lix predictivevalueofmir9asapotentialbiomarkerfornasopharyngealcarcinomametastasis |